Akash R. Boda

The University of Texas MD Anderson Cancer Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege”.

High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003246

N/A

0.650DataRank · unranked

75 citations

Akash R. Boda, Kimal Rajapakshe, Spencer T. Lea, Maria Emilia Di Francesco, Priyamvada Jayaprakash +9 more

Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration

JCI Insight(2023)10.1172/jci.insight.169150

N/A

0.373DataRank · unranked

11 citations

Seth T. Gammon, Federica Pisaneschi, Akash R. Boda, Casey R. Ager, David Piwnica‐Worms +3 more

Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0095

N/A

0.241DataRank · unranked

4 citations

Arthur Liu, Susana Castro-Pando, Benjamin T. Whitfield, Jeffrey J. Molldrem, Gheath Alatrash +5 more

592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.592

N/A

0DataRank · unranked

8 citations

Sunil Krishnan, Ren‐Chin Wu, Akash R. Boda, Arthur Liu, Michelle Winkler +29 more